Lab Kingpin Gets 27 Years in $463M Medicare Scam

A Georgia lab owner is trading his white coat for an orange jumpsuit after a federal court slammed him with a 27-year sentence for a brazen $463 million Medicare scam. Minal Patel, who ran LabSolutions LLC, wasn’t just cutting corners – he was systematically bleeding the healthcare system dry with bogus cancer genetic tests.

Patel didn’t work alone. He built a network of hustlers – patient brokers, shady telemedicine outfits, and relentless call centers – to target vulnerable Medicare recipients. The pitch? False promises that Medicare would foot the bill for expensive genetic tests they didn’t need. It was a high-volume operation, preying on the elderly and those with limited understanding of their healthcare benefits.

The scheme was simple in its cruelty. Patel paid kickbacks – straight-up bribes – to patient brokers for every signed doctor’s order they procured. These orders authorized unnecessary tests, and Patel went to great lengths to cover his tracks, using sham contracts to disguise the illegal payments as legitimate advertising expenses. It was a classic case of greed masquerading as business.

Federal prosecutors laid out a clear picture of how the scheme operated. Call centers would flood Medicare beneficiaries with calls, pushing these unnecessary tests. Once a patient agreed, a broker would secure a doctor’s signature (often through questionable means) and LabSolutions would bill Medicare. The feds traced over $187 million in fraudulent payments, with Patel personally pocketing over $21 million.

“This isn’t just about money,” said Nicole M. Argentieri, the Acting Assistant Attorney General leading the case. “It’s about exploiting patients and draining resources from a system designed to care for them. This sentence sends a message: we will relentlessly pursue those who prioritize profit over people’s health.” The investigation, a joint effort between the FBI and the HHS-OIG, uncovered a web of deceit and blatant disregard for the law.

The 27-year sentence is a significant victory for federal prosecutors, but it’s likely just the tip of the iceberg. The feds are continuing to investigate Patel’s co-conspirators – the brokers, telemedicine companies, and call center operators who helped facilitate the fraud. Expect more indictments and convictions to follow as the Justice Department cracks down on the rampant abuse within the genetic testing industry. This case, dubbed “Operation Double Helix,” underscores the government’s commitment to protecting Medicare from predatory schemes.

Asset forfeiture proceedings are underway to recoup some of the ill-gotten gains. While it won’t fully compensate for the damage done, it’s a step towards holding Patel and his associates accountable. The feds are looking to seize Patel’s personal assets, as well as any profits earned by his co-conspirators.

This case is part of a larger trend of healthcare fraud investigations. Federal prosecutors are increasingly focused on telemedicine and genetic testing schemes, recognizing the potential for widespread abuse. They’re warning healthcare providers and businesses that they will be held responsible for any fraudulent activities, no matter how sophisticated.

RELATED: Reseda Gun & Meth Kingpin Gets 12 Years in Federal Lockup

RELATED: Meth Kingpin Gets 10 Years: Missouri Man Fueled Illinois Drug Trade